Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors

Patients with solid tumors have been a risk group since the beginning of the SARS‐CoV‐2 pandemic due to more significant complications, hospitalizations or deaths. The immunosuppressive state of cancer treatments or the tumor itself could influence the development of post‐vaccination antibodies. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Felip, Eudald, Pradenas, Edwards, Romeo, Margarita, Marfil, Silvia, Trinité, Benjamin, Urrea, Víctor, Hernández, Ainhoa, Ballana, Ester, Cucurull, Marc, Mateu, Lourdes, Massanella, Marta, Clotet, Bonaventura, Morán, Teresa, Blanco, Julià
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877816/
https://www.ncbi.nlm.nih.gov/pubmed/36495129
http://dx.doi.org/10.1002/1878-0261.13359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877816/
https://www.ncbi.nlm.nih.gov/pubmed/36495129
http://dx.doi.org/10.1002/1878-0261.13359

Ejemplares similares